(NASDAQ:SNPS), SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Synopsys, Inc. (NASDAQ: SNPS), a leading electronic design automation (EDA) company, is facing a significant leadership shakeup and escalating legal pressure, highlighted by the recent departure of its Chief Revenue Officer (CRO). The company announced in a Form 8-K filing on November 4, 2025, that Rick […]

Toronto, Ontario–(Newsfile Corp. – Le 24 novembre/November 2025) - PreveCeutical Medical Inc. (“PreveCeutical”) has announced the effective date of the reclassification as well as the previously announced plan of arrangement with BioGene Therapeutics Inc. (“BioGene”) to occur on November 25, 2025. Pursuant to the Arrangement Agreement (the “Arrangement Agreement”) 12,000,000 common shares of BioGene Therapeutics Inc.

Synopsys (SNPS) Exists Amidst Securities Class Action, IP Unit Scrutiny– Hagens Berman SNPS Investors with Losses Encouraged to Contact the Firm GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Synopsys, Inc. (NASDAQ: SNPS), a leading electronic design automation (EDA) company, is facing a significant leadership shakeup and escalating legal pressure, highlighted

New York, New York–(Newsfile Corp. – November 24, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Firefly Aerospace Inc. (NASDAQ: FLY) resulting from allegations that Firefly Aerospace may have issued materially misleading business information to the investing public. SO WHAT:

(NASDAQ:TLX), SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit, capping a tumultuous several months that saw the company's stock crater following revelations of a regulatory subpoena and an FDA

(NASDAQ:DXCM), RADNOR, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between January 8, 2024, and September 17, 2025,

Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter — Hagens Berman TLX Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is

DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP GlobeNewswire November 24, 2025 RADNOR, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against

(NYSE:KMX), SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — On November 6, 2025, investors in CarMax, Inc. (NYSE: KMX) saw shares plummet $9.93 (-24%) after the company announced that it fired CEO Bill Nash and issued its new Q3 2026 preliminary outlook on comparable store used unit sales, calling for a decline of 8%-12% from

CarMax, Inc. (KMX) Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline, Class Action Pending — Hagens Berman KMX Investors with Losses Encouraged to Contact the Firm GlobeNewswire November 24, 2025 SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) — On November 6, 2025, investors in CarMax, Inc. (NYSE: KMX) saw shares plummet